|
|
 |
|
Viewing report
|
|
|
|
China Listed Bio-pharmaceutical Companies Report, 2008
Research In China, May 2009, Pages: 98
This report firstly gives an overview of China bio-pharmaceutical industry, and then analyses sub-industries, import & exports status of the industry; finally it expounds the operations and revenue, project investment, main business structure, latest development and future trend of key 20 bio-pharmaceutical companies.
Sales revenue of bio-pharmaceutical industry in Jan-Nov 2008 raised 29.8% compared with the same period of 2007, up 7.6 points; Sales cost saw a 33.9% YoY rise; and gross profit margin grew 28.2% year-on-year, down 2.5 percentage points. The rate of period expense was 15.8%, down 1.2 points from the same period of 2007.
In 2008, China exported 1,632.14 tons of human & animal blood products, antiserum and vaccines, down 29.7% year on year; the export value totaled US$56.92 million, down 85.3%; the export price per unit was US$34.87/kg, US$16.96/kg lower than 2007.
In addition, the import volume of human & animal blood products, antiserum and vaccines amounted to 8,977.90 tons, up 2.87 times; the import value totaled US$558.16 million, up 44.3%; unit import price was US$62.17/kg, US$167.37/kg lower than 2007.
Customers who bought this item also bought
Asia Telecom Industry Report, 2008-2009
Global and China Mobile Phone Manufacture Industry Report, 2010-2011
Global and China Mobile Phone Manufacture Industry Report, 2010-2011
Cancer Therapies - Global Strategic Business Report
China FPC Industry Report, 2006-2007
Research Report on China's Mobile Value-Added Service Industry, 2009
Global and China Flexible Printed Circuit Board (FPCB) Industry Report, 2010-2011
Global and China Flexible Printed Circuit Board (FPCB) Industry Report, 2010-2011
South Korea Telecom Investment Environment Report, 2008-2009
China's RFID (Radio Frequency ID) Market Study, 2005-2006
|
|
|
|
